resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
3f5dbc86-c52d-4713-8a03-ddf3ae42695f,c.5425C > T NF1-mutant hiPSCs,['Cell Line'],The c.5425C > T NF1-mutant hiPSCs cell line was generated using CRISPR/Cas9 technology from a control human iPSC line to introduce the patient-derived NF1 mutation.,"['Cell line generation', 'Genomics']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3f5dbc86-c52d-4713-8a03-ddf3ae42695f,c.5425C > T NF1-mutant hiPSCs,['Cell Line'],The c.5425C > T NF1-mutant hiPSCs cell line exhibited increased RAS activity compared to the control iPSC line.,['Signaling'],,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3f5dbc86-c52d-4713-8a03-ddf3ae42695f,c.5425C > T NF1-mutant hiPSCs,['Cell Line'],Brain organoids were successfully generated from the c.5425C > T NF1-mutant hiPSCs cell line.,['Differentiation potential'],,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3f5dbc86-c52d-4713-8a03-ddf3ae42695f,c.5425C > T NF1-mutant hiPSCs,['Cell Line'],The c.5425C > T NF1-mutant hiPSCs cell line was derived from a patient with neurofibromatosis type 1 (NF1) and harbors a representative NF1 patient mutation.,"['Disease relevance', 'Genomics']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
